These findings supported the conclusion that LRRC56 can promote cancer cell proliferation and facilitate BC metastasis by modulating cytoskeletal reorganization, primarily through its regulation of the RhoA/ROCKs signaling pathway. Here, LRRC56 is linked to breast cancer.